Shares of the AcelRx Pharmaceuticals, Inc stock were rising in the current market session today on December 15, 2021. ACRX stock price saw an uptrend of 5.62% to reach $0.533 a share at the time of this writing. The trading volume on the last check was 1,855,405, far higher than the average trading volume. Let’s …
Why AcelRx Pharmaceuticals, Inc. (ACRX) stock is surging today? Read More »
Shares of the Spring Valley Acquisition Corp. (SV) stock were rising in the current market trading session today on December 15, 2021. SV stock price saw a push of 1.60% to reach $10.15 a share as of this writing. The stock was also green in the previous trade and went up by 0.40% at closing. …
Spring Valley Acquisition Corp. (SV) stock extending gains today: Here’s Why Read More »
Shares of Uxin Limited (UXIN) rallied in the current market following the announcement of the unaudited second quarter of the fiscal year 2022 financial results. UXIN stock price saw a rise of 5.95% to reach $1.78 a share at the time of this writing. The stock was gloomy in the previous trade and went down …
Uxin Limited (UXIN) stock rallied in the current market: Let’s find out why Read More »
Solana has garnered a name for itself that now stands unparallel in the market. The cryptocurrency and its network have seen phenomenal growth. SOL token operated at a price level below $1 before 2021 but the bull run of 2021 brought it under a perpetual limelight as the current price now lies in triple digits. …
Solana’s projects working towards bridging the gap Read More »
Venus peaked during the high of the 2021 bull run in May. The cryptocurrency suffered from brutal market corrections ever since and has failed to ride the bullish wave again. The all-time high was established at a price level of $138 while the price subsequently declined to double-digits. At the time of writing, the cryptocurrency …
Elrond picked up the bullish momentum towards the end of November and established a new all-time high at $490. The token subsequently suffered from market corrections – as expected. However, the current performance shows a trend reversal as the bulls begin to dominate the bears for the cryptocurrency. At the time of writing, EGLD token …
Dusk Network peaked during the high of the 2021 bull run in April. Afterwards, the token fell prey to brutal market corrections but that period has ended long ago. The cryptocurrency began consolidating during November; however, it was not able to break upwards and suffered from a steep downturn but instead of moving into corrections, …
Dusk Network – Release of the second biannual report Read More »
Legend Biotech Corporation (LEGN) lost a further 8.43% at $44.45 premarket, at the last check on Wednesday. The stock has been trading in the red since the company announced a proposed public offering on December 14. In the previous session, the stock moved between $48.18 and $50.56, to close at $48.54. Hence, LEGN stock lost …
Following the Q2 fiscal 2022 earnings, Aspen Group Inc. (ASPU) plummeted further by 28% premarket. The company announced its second-quarter financial results for fiscal 2022, on December 14. During regular trading, the stock varied between a high of $2.7631 and a low of $2.60. At a volume of 477.77 thousand shares, ASPU closed the session …
Q2 Fiscal 2022 Earnings: Aspen Group Inc. (ASPU) stock extend losses in the Pre Market Read More »
Idera Pharmaceuticals Inc. (IDRA) stock lost a further 12.76% in the after-hours, while it was down by 1.14% in regular trading. On December 14, the company provided updates for its tilsotolimod, which did not impress the investors. In the regular session, the stock traded between $0.8405 and $0.9490, at a volume of 3.02 million shares. …
Tilsotolimod’s Updates: Idera Pharmaceuticals Inc. (IDRA) stock slid further After Hours Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.